In July 2019, enigmatic multi-billionaire and tech idol Elon Musk made a highly anticipated announcement about his brain-computer interface company NeuraLink. Despite the ensuing excitement, the device it has developed...
12 August 2019 Analysis
12 August 2019 News
Swedish designer and manufacturer of implants for bone regeneration, OssDsign has filed for Japanese regulatory approval of OssDsign Cranial.
9 August 2019 News
Apple has joined forces with Eli Lilly and Evidation Health on a new feasibility study to detect evidence of brain decline with data from personal digital devices.
8 August 2019 News
Synaptive Medical has launched surgical planning tool Modus Plan, featuring BrightMatter AutoSeg, for neurosurgeons in the US.
7 August 2019 News
NeuroEM Therapeutics has reported positive data from the trial of a transcranial electromagnetic treatment (TEMT) with the company’s investigational MemorEM head device to treat Alzheimer’s disease (AD).
31 July 2019 News
Patients with paralysis-related speech loss could benefit from a new technology developed by University of California San Francisco (UCSF) researchers that turns brain signals for speech into written sentences.
24 July 2019 Comment
Cluster headache patients experience excruciating and debilitating attacks of pain that differs from tension headache in the location, severity of pain and frequency of attacks. GammaCore, is a portable, non-drug,...
23 July 2019 News
Medical device company Flow has announced that it has raised $1.5m towards its transcranial direct current stimulation (tDCS) device for the treatment of depression.
27 June 2019 Comment
Brain-computer interface (BCI) research is a rapidly evolving field with growing clinical interest for systems that allow patients suffering from neurological disorders to independently interact with their environment.
26 June 2019 News
Researchers from the National University of Singapore (NUS) have invented a new blood test known as Amplified Plasmonic Exosome (Apex), capable of detecting a molecule that indicates early-stage Alzheimer's disease...